Moleculin Biotech, Inc. — Director's Dealing 2016

Jun 8, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Moleculin Biotech, Inc. (MBRX)
CIK: 0001659617
Period of Report: 2016-06-02

Reporting Person: PLOTH LOUIS JR (Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to purchase common stock	$0.20	2025-12-10	Common Stock (200000)		Direct

Footnotes

F1: The reporting person holds an option to purchase 200,000 shares vesting in equal annual installments over a four-year period commencing December 10, 2017, provided the reporting person is employed on each vesting date.